News
Mutation in DOCK11 gene explains rare disorder in immune system regulation
Researchers from the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital participate in an international study, published in the prestigious scientific journal New England Journal of Medicine, which describes for the first time a new disease of the immune system caused by a mutation of the DOCK11 gene.
Gate2Brain Receives EMA Orphan Drug Designation for Its Groundbreaking Pediatric Cancer Treatment
Gate2Brain, has reached a major milestone in the fight against pediatric brain tumors by obtaining Orphan Drug Designation (ODD) from the European Medicines Agency (EMA) for its innovative product, G2B-002.
SJD Barcelona Children's Hospital and Institut de Recerca Sant Joan de Déu (IRSJD) consolidate their participation in the ISCiii Biomedicine and Health platforms
Members of the innovation team from the SJD Barcelona Children's Hospital and the Institut de Recerca Sant Joan de Déu (IRSJD) participated in the II Scientific Conferences promoted by the Instituto de Salud Carlos III (ISCiii), held in Lleida from October 28 to 30.
A drug capable of simultaneously targeting three different therapeutic targets is designed.
The study, published in the journal Bioorganic Chemistry, presents a proof of concept for this innovative triple-effect compound, which has been successfully applied to breast cancer cells. According to experts, this therapy has "high potential for the treatment of complex diseases such as cancer or diabetes.
Agenda
#ViernesCientíficos | Diseño de un dispositivo de contención neonatal: Innovación enfermera
Seminario a cargo de Silvia Vicente Pérez. Enfermera Especialista en Pediatría. Experta en innovación en el ámbito de la salud y profesora titular de l'Escola Universitària d'Infermeria Sant Pau de Barcelona.
Defensa tesi doctoral: Leire Balaguer Lluna
"Inhibition of the PI3K/Akt pathway as a therapeutic strategy for pediatric-type diffuse high-grade gliomas"
Interviews
Manel González-Piñero
Headof Innovation at CREB UPC and XarTEC SALUT
"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."
Read more More Interviews